Description
IMPAVIDO DRUG
Base award description: IMPAVIDO CONSIGNMENT AGREEMENT
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-06-30+$0= $0
- Mod P000012021-07-01+$0= $0
- Mod P000032022-07-01+$0= $0
- Mod P000042023-09-14+$0= $0
- Mod P000052024-06-28+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-06-30 | +$0 | $0 | IMPAVIDO CONSIGNMENT AGREEMENT |
| Mod P00001· EXERCISE AN OPTION | 2021-07-01 | +$0 | $0 | OPTION 1 IMPAVIDO CONSIGNMENT AGREEMENT |
| Mod P00003· EXERCISE AN OPTION | 2022-07-01 | +$0 | $0 | OPTION 2 IMPAVIDO CONSIGNMENT AGREEMENT |
| Mod P00004· EXERCISE AN OPTION | 2023-09-14 | +$0 | $0 | IMPAVIDO DRUG |
| Mod P00005· EXERCISE AN OPTION | 2024-06-28 | +$0 | $0 | IMPAVIDO DRUG |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NR1ZD3ETM3N6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826D0041 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26326P0460 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $49,950 | FY2026 |
| 36C26025P0684 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $49,950 | FY2025 |
| 36C26025P0535 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $99,900 | FY2025 |
| 36C26025P0490 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $49,950 | FY2025 |
| 36C26025P0452 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $16,650 | FY2025 |
Other recipients under 6505 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826F0207 | CSL BEHRING L.L.C. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $183,903 | FY2026 |
| 36C24826P1108 | ASD SPECIALTY HEALTHCARE, LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $54,600 | FY2026 |
| 36C24826P1090 | SIRTEX MEDICAL INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $45,825 | FY2026 |
| 36C24826N0511 | BIOMERIEUX INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $61,788 | FY2026 |
| 36C24826N0693 | MEDI-PHYSICS, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $111,150 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36C24820A0030_3600 · retrieved 2026-09-26.